UBS Group’s Artivion AORT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
– Sell
-1,500
Closed -$17K – 8764
2014
Q4
$17K Buy
+1,500
New +$15.5K ﹤0.01% 7859

Other funds holding AORT

UBS Group's AORT Position: Q3 2026 in Review

UBS Group reduced its Artivion (AORT) stake by 24% in Q3 2026, selling an estimated $2.82M and leaving 344,557 shares worth $7.86M. The position accounts for ﹤0.01% of the portfolio, ranked #3637.

UBS Group first reported a position in AORT in Q4 2014 and has held it in 48 quarters since. The position peaked at $12.8M in Q4 2025. 217 funds tracked by Wall St. Rank hold AORT as of Q3 2026.

  • UBS Group held 344,557 shares of Artivion worth $7.86M as of Q3 2026.
  • UBS Group sold 109,844 Artivion shares in Q3 2026, an estimated $2.82M.
  • Artivion made up ﹤0.01% of UBS Group's portfolio in Q3 2026, its #3637 holding.
  • UBS Group first reported a position in Artivion in Q4 2014 and has held it in 48 quarters since.
  • UBS Group's Artivion position peaked at $12.8M in Q4 2025.
  • 217 funds tracked by Wall St. Rank held Artivion as of Q3 2026.

Based on UBS Group's 13F filing for Q3 2026, filed 10 Nov 2026.